Daily Archives: June 6, 2022
Updated WHO recommendations for malaria chemoprevention and elimination.
6 Jun, 2022 | 12:07h | UTCNews Release: Updated WHO recommendations for malaria chemoprevention and elimination – World Health Organization
Original Document: WHO Guidelines for malaria – World Health Organization
Commentary on Twitter (thread – click for more)
? Guidelines for malaria provide recommendations for countries from malaria chemoprevention & mass drug administration to #EndMalaria.
More info ?https://t.co/rOZpxBjBiL pic.twitter.com/5tv5SZ07E7
— World Health Organization (WHO) (@WHO) June 3, 2022
Oncologic emergencies and urgencies: A comprehensive review.
6 Jun, 2022 | 12:06h | UTCOncologic emergencies and urgencies: A comprehensive review – CA: A Cancer Journal for Clinicians
Commentary on Twitter
?Just in time for #ASCO22 | Oncologic emergencies and urgencies: A comprehensive review https://t.co/HyZmI37tr5 @BEGouldRothberg @YaleCancer @KeithDelman
CC: @OncoAlert pic.twitter.com/57tqiLXijN— CA: A Cancer Journal for Clinicians (@CAonline) June 2, 2022
#ADA2022 – ADA Consensus Report | Heart Failure: An underappreciated complication of diabetes.
6 Jun, 2022 | 12:02h | UTC
#ADA2022 – RCT: Tirzepatide once weekly for the treatment of obesity.
6 Jun, 2022 | 11:59h | UTCTirzepatide Once Weekly for the Treatment of Obesity – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
SURMOUNT-1: In an RCT, adults with obesity treated with weekly tirzepatide had major weight loss over 72 weeks. #ADA2022 https://t.co/X2RrvYxzsV pic.twitter.com/X27bWp1Qod
— NEJM (@NEJM) June 4, 2022
#ADA2022 – RCT: Once-weekly dulaglutide for the treatment of youths with type 2 diabetes.
6 Jun, 2022 | 11:57h | UTCOnce-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Once Weekly Drug Helps Control Pediatric Type 2 Diabetes – American Diabetes Association
Commentary on Twitter
Trial compared once-weekly dulaglutide with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks. #ADA2022 https://t.co/P6PubXvHOR pic.twitter.com/1JPIT5IyTe
— NEJM (@NEJM) June 4, 2022
#ASCO22 – RCT: Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer.
6 Jun, 2022 | 11:53h | UTCCirculating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: ctDNA Effectively Detects When Adjuvant Chemo Is Avoidable in Stage II Colon Cancers – Cancer Network
Commentary on Twitter
DYNAMIC: Among patients with stage II colon cancer, a ctDNA-guided management approach reduced the use of adjuvant chemotherapy without increasing the risk of recurrence. #ASCO22 https://t.co/xXjXyPXRC9 pic.twitter.com/gvHMnGWbyE
— NEJM (@NEJM) June 4, 2022
#ADA2022 – Retrospective Cohort Study: Association of bariatric surgery with cancer risk and mortality in adults with obesity.
6 Jun, 2022 | 11:54h | UTCAssociation of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity – JAMA (free for a limited period)
Editorial: Bariatric Surgery and Cancer Risk – JAMA (free for a limited period)
News Release: Weight loss with bariatric surgery cuts the risk of developing cancer and death from cancer – Cleveland Clinic
Commentaries on Twitter
In this study, among adults with #obesity, #bariatricsurgery compared with no surgery was associated with a significantly lower incidence of obesity-associated #cancer and cancer-related mortality. https://t.co/x2gz3RUdra
— JAMA (@JAMA_current) June 3, 2022
Retrospective cohort presented at the @AmDiabetesAssn: incidence rate of 3.0 events vs 4.6 events per 1,000 person-years, resp, & a 32% reduced risk for developing obesity-related cancer following weight loss via surgery. @ClevelandClinic
https://t.co/6jLDmhgJbR @JAMA_current
— Karl Nadolsky (@DrKarlNadolsky) June 4, 2022
#EULAR2022 – RCT: Low dose, add-on prednisolone in patients with rheumatoid arthritis over 65 years.
6 Jun, 2022 | 11:51h | UTCCommentaries:
Chronic, low-dose glucocorticoid benefits outweigh harms in senior patients with RA – medwire News
Trial Upends Guidelines on Long-Term Steroids in Rheumatoid Arthritis — Vindication for clinicians who ignored official recommendations – MedPage Today (free registration required)
Experts highlight sexual aspect of monkeypox spread.
6 Jun, 2022 | 11:39h | UTCExperts highlight sexual aspect of monkeypox spread – CIDRAP
Related:
What to Know About Monkeypox – JAMA
Multi-country monkeypox outbreak in non-endemic countries: Update – World Health Organization
Monkeypox outbreaks: 4 key questions researchers have – Nature
Study reports first use of antivirals in monkeypox patients – Lancet
Surveillance, case investigation and contact tracing for Monkeypox – World Health Organization
Laboratory testing for the monkeypox virus: Interim guidance – World Health Organization
A Novel International Monkeypox Outbreak – Annals of Internal Medicine
EU health agency warns monkeypox could become endemic in Europe if outbreak continues – STAT
Monkeypox cases increase across Europe, North America – CIDRAP
Multi-country monkeypox outbreak in non-endemic countries – World Health Organization
Monkeypox goes global: why scientists are on alert – Nature
Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT
Monkeypox: Time to worry or one to ignore? – BBC
UK, Spain, Portugal report more monkeypox cases – CIDRAP
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
Consensus Statement: Diagnostic action against hypertransaminasemia in pediatrics.
6 Jun, 2022 | 11:23h | UTC
Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread.
6 Jun, 2022 | 11:42h | UTCSee also: 2 monkeypox strains in US suggest possible undetected spread – Associated Press
Related:
What to Know About Monkeypox – JAMA
Multi-country monkeypox outbreak in non-endemic countries: Update – World Health Organization
Monkeypox outbreaks: 4 key questions researchers have – Nature
Study reports first use of antivirals in monkeypox patients – Lancet
Surveillance, case investigation and contact tracing for Monkeypox – World Health Organization
Laboratory testing for the monkeypox virus: Interim guidance – World Health Organization
A Novel International Monkeypox Outbreak – Annals of Internal Medicine
EU health agency warns monkeypox could become endemic in Europe if outbreak continues – STAT
Monkeypox cases increase across Europe, North America – CIDRAP
Multi-country monkeypox outbreak in non-endemic countries – World Health Organization
Monkeypox goes global: why scientists are on alert – Nature
Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT
Monkeypox: Time to worry or one to ignore? – BBC
UK, Spain, Portugal report more monkeypox cases – CIDRAP
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
Consensus Statement: Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management.
6 Jun, 2022 | 11:22h | UTC
Guidelines for the Kaposi Sarcoma.
6 Jun, 2022 | 11:20h | UTCS1 Guidelines for the Kaposi Sarcoma – Journal of the German Society of Dermatology
#ASCO22 – RCT: Trastuzumab Deruxtecan in previously treated HER2-low advanced breast cancer.
6 Jun, 2022 | 11:18h | UTCTrastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
DESTINY-Breast04: In a phase 3 trial, trastuzumab deruxtecan resulted in longer progression-free and overall survival than the physician’s choice of chemo among patients with HER2-low breast cancer. #ASCO22 https://t.co/bgheQ1yolb pic.twitter.com/nfRMcIh9Ly
— NEJM (@NEJM) June 5, 2022
#ASCO22 – RCT: Ibrutinib plus Bendamustine and Rituximab in untreated Mantle-Cell Lymphoma.
6 Jun, 2022 | 11:16h | UTCIbrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma – New England Journal of Medicine (link to abstract – $ for full-text)
Difficult and complicated oral ulceration: an expert consensus guideline for diagnosis.
6 Jun, 2022 | 11:19h | UTC
#ASCO22 – Phase 2 single-arm study: Adagrasib in non–small-cell lung cancer harboring a KRASG12C mutation.
6 Jun, 2022 | 11:15h | UTCAdagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Targeted drug achieves 43% response rate in KRAS-mutated lung cancer – Dana-Farber Cancer Institute
#ASCO22 – Phase 2 single-arm study: PD-1 Blockade in mismatch repair–deficient, locally advanced rectal cancer.
6 Jun, 2022 | 11:12h | UTCPD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
#ASCO22 – Phase II RCT: Ramucirumab and pembrolizumab vs. standard of care in advanced non–small-cell lung cancer previously treated with immunotherapy.
6 Jun, 2022 | 11:14h | UTCCommentary: New drug combination lengthened survival for some with lung cancer – SWOG Cancer Research Network
Commentary on Twitter
? #ASCO22 simultaneous pub: Lung-MAP study finds ramucirumab ➕ pembro improved OS in pts w #NSCLC previously treated w/ immune ✔️point inhibitors & chemo. https://t.co/M0zL95ddxD @ReckampK @DrRoyHerbstYale #lcsm
— Journal of Clinical Oncology (@JCO_ASCO) June 3, 2022
#ASCO22 – RCT: Triplet therapy, transplantation, and maintenance until progression in myeloma.
6 Jun, 2022 | 11:06h | UTCTriplet Therapy, Transplantation, and Maintenance until Progression in Myeloma – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
DETERMINATION: Among adults with multiple myeloma, continuous lenalidomide maintenance therapy after triplet therapy (RVD, plus ASCT) associated with longer PFS than triplet therapy alone. #ASCO22 https://t.co/YhKgjc1Enz pic.twitter.com/cU8nefokZo
— NEJM (@NEJM) June 5, 2022
#ASCO22 – Phase 1-2 single-arm study: Teclistamab in relapsed or refractory multiple myeloma.
6 Jun, 2022 | 11:11h | UTCTeclistamab in Relapsed or Refractory Multiple Myeloma – New England Journal of Medicine
Commentary on Twitter
MajesTEC-1: Teclistamab resulted in a high incidence of deep and durable response in patients with triple-class–exposed relapsed or refractory multiple myeloma. #ASCO22 https://t.co/Nanjob1q7p pic.twitter.com/oqfaiu8MOx
— NEJM (@NEJM) June 5, 2022
RCT: Computer-aided device improves adenoma detection in colonoscopy for screening and surveillance colonoscopy.
6 Jun, 2022 | 11:03h | UTCCommentary: Colonoscopy With a Computer-Aided Device Boosted Adenoma Detection — Use of the device led to a 27% increase in adenomas per colonoscopy versus standard procedure – MedPage Today (free registration required)
M-A: Routine abdominal drainage after distal pancreatectomy.
6 Jun, 2022 | 11:01h | UTCRoutine abdominal drainage after distal pancreatectomy: meta-analysis – British Journal of Surgery
Commentary on Twitter
In the June issue of BJS: Routine abdominal drainage after distal pancreatectomy: meta-analysis https://t.co/dQrOnvtVB7 @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs pic.twitter.com/KqHx7Gg0JH
— BJS (@BJSurgery) June 5, 2022
RCT: Effect of intraoperative handovers of anesthesia care on mortality, readmission, or postoperative complications among adults.
6 Jun, 2022 | 11:04h | UTCEffect of Intraoperative Handovers of Anesthesia Care on Mortality, Readmission, or Postoperative Complications Among Adults: The HandiCAP Randomized Clinical Trial – JAMA (free for a limited period)
Related Study: Association Between Handover of Anesthesia Care and Adverse Postoperative Outcomes Among Patients Undergoing Major Surgery – JAMA
Commentary on Twitter
In this RCT, among adults undergoing extended surgical procedures, there was no difference bw handover of anesthesia care compared w no handover of care in the primary outcome of mortality, readmission, & serious postoperative complications within 30 days.https://t.co/FpGFZk47x7
— JAMA (@JAMA_current) June 4, 2022
Cohort Study: Intrauterine device-related uterine perforation incidence and risk.
6 Jun, 2022 | 10:59h | UTCIntrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
Although the risk for uterine perforation with IUD insertion 4 days to 6 weeks or less postpartum is nearly 7x that of insertion non-postpartum, perforation remains an incredibly rare event for all clinical time pointshttps://t.co/DPqgLAh1Dx
— The Lancet (@TheLancet) June 3, 2022